GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending March 31, 2019 and Host Conference Call on May 6, 2019
Conference call information will be provided in the financial results press release.
Read MoreSelect Page
Posted by Invest In Weed | Apr 23, 2019
Conference call information will be provided in the financial results press release.
Read MorePosted by Invest In Weed | Apr 22, 2019
In its 2018 financial statement, the company reported over $1.2 million in revenue for year-end December 31, 2018 with over $500,000 in net profit.
Read MorePosted by Invest In Weed | Apr 18, 2019
Hemp, Inc. showed over an 1,800% increase in sales from previous year 2017.
Read MorePosted by Invest In Weed | Apr 17, 2019
The company’s largest shareholder made a selfless decision to show their belief in the future of the Company by selling shares back to MJ Holdings, Inc. at their original cost, which enabled the company to resell some of those shares for more than $5,000,000 without any dilution to its existing shareholders.
Read MorePosted by Invest In Weed | Apr 17, 2019
Fourth Quarter 2018: 118% Year-Over-Year Revenue GrowthFiscal 2018: 95% Revenue Year-Over-Year Growth; Adjusted EBITDA up 53%Strategic Investments Position MariMed for Dynamic Growth in Cannabis and Hemp CBD.
Read MoreGet stock alerts, news & related alerts straight to your inbox!